Robert Weinstein Institution Verified
Sourced from institutional research profiles (UAMS TRI or ARA).
Professor
University of Arkansas for Medical Sciences
faculty
Internal Med, College of Medicine
Research Areas
Biography and Research Information
OverviewAI-generated summary
Robert Weinstein, M.D., is a professor of medicine in the Division of Endocrinology and Metabolism at the University of Arkansas for Medical Sciences. He completed his medical degree at the University of Illinois Medical Center and a post-doctoral fellowship in Endocrinology at the University of Miami School of Medicine. Dr. Weinstein is a Diplomat of the American Board of Internal Medicine, holding certifications in Internal Medicine and Endocrinology and Metabolism. His professional memberships include the American Association for the Advancement of Science, the American Society for Bone and Mineral Research, the Endocrine Society, and the Arkansas Medical Society.
Research Overview
Robert S. Weinstein, M.D. is a professor of medicine in the Division of Endocrinology and Metabolism. He received his medical degree from the University of Illinois Medical Center in Chicago. He completed a post-doctoral fellowship in Endocrinology from the University of Miami School of Medicine.Dr. Weinstein is a Diplomat with the American Board of Internal Medicine, with specialties in Internal Medicine and Endocrinology and Metabolism. He is also a member of the American Association for the Advancement of Science, the American Society for Bone and Mineral Research, the Endocrine Society and the Arkansas Medical Society.
Grants & Funding
- Glucocorticoid-induced osteonecrosis of the hip, osteocytes and canalicular fluid NIH Principal Investigator
- Bisphosphonate effects on osteoclasts and osteocytes in vitro: mechanisms of inhibition of glucocorticoid-induced apoptosis of osteocytes Procter & Gamble Principal Investigator
- A Multi-Center, Double-blind, randomized, placebo-controlled study to evaluate the safety and efficacy of Zoledronic acid in the treatment of osteopor NOVARTIS Pharmaceuticals Corporation Principal Investigator
- Bisphosphonate effects on osteoclasts and osteocytes in glucocorticoid-induced osteoporosis: relationship to fracture prevention. Procter & Gamble Principal Investigator
- Bisphosphonate effects on osteoclasts and osteocytes in vitro: mechanisms of inhibition of glucocorticoid-induced apoptosis of osteocytes Procter & Gamble Principal Investigator
- A Multi-Center, Double-blind, randomized, placebo-controlled study to evaluate the safety and efficacy of Zoledronic acid in the treatment of osteopor NOVARTIS Pharmaceuticals Corporation Principal Investigator
- Osteocyte Control of Bone Remodeling NIH/Nat. Inst. of Arthritis & Musculoskeletal & Skin Diseases Co-Investigator
- Interference with RANKL Prevents Increased Cancellous Osteoclast Number and Lifespan in Mice Receiving Excess Glucocorticoids Amgen, Inc. Principal Investigator
Frequent Collaborators
Similar Researchers
Based on overlapping research topics